A comprehensive view of Grifols Worldwide. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
IrsiCaixa-led researchers develop two new SARS-CoV-2 vaccine candidates offering enhanced immunogen production, effective against omicron, beta, and D614G variants; Grifols funded study suggests potential for next-generation vaccines
Published:
March 22, 2024
by CE Noticias Financieras
|
Ask us about our Health Care Sector market view